Sinopharm Group Co. Ltd Free Cash Flow Generation Index
Sinopharm Group Co. Ltd free cash flow generation index. Sinopharm Group Co. Ltd (X2S) has a Free Cash Flow Generation Index of 0.98x as of December 2022. Free cash flow of €51.45 Billion represents 1% of operating cash flow (€52.39 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Sinopharm Group Co. Ltd (2013–2025)
Free cash flow generation index of Sinopharm Group Co. Ltd from 2013 to 2025. Historical FCF Generation Index trend for Sinopharm Group Co. Ltd across 13 annual periods. See X2S FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Sinopharm Group Co. Ltd Free Cash Flow Generation Index by Year (2013–2025)
Sinopharm Group Co. Ltd free cash flow generation index by year from 2013 to 2025. Year-by-year Free Cash Flow Generation Index for Sinopharm Group Co. Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Sinopharm Group Co. Ltd.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.89x | €12.52 Billion | €14.14 Billion | €1.62 Billion | ▲ +6.8% |
| 2024 | 0.83x | €9.58 Billion | €11.55 Billion | €1.97 Billion | ▼ -4.0% |
| 2023 | 0.86x | €14.84 Billion | €17.17 Billion | €2.34 Billion | ▼ -2.3% |
| 2022 | 0.88x | €18.55 Billion | €20.96 Billion | €2.13 Billion | ▼ -11.5% |
| 2021 | 1.00x | €9.31 Billion | €9.31 Billion | €2.07 Billion | ▲ +0.0% |
| 2020 | 1.00x | €11.15 Billion | €11.15 Billion | €1.90 Billion | ▲ +15.7% |
| 2019 | 0.86x | €16.23 Billion | €18.78 Billion | €2.21 Billion | ▲ +1165.0% |
| 2018 | 0.07x | €249.62 Million | €3.65 Billion | €3.24 Billion | ▲ +196.4% |
| 2017 | -0.07x | €-227.35 Million | €3.21 Billion | €2.12 Billion | ▼ -106.2% |
| 2016 | 1.15x | €10.62 Billion | €9.26 Billion | €1.36 Billion | ▲ +6.6% |
| 2015 | 1.08x | €14.43 Billion | €13.41 Billion | €1.02 Billion | ▼ -14.7% |
| 2014 | 1.26x | €7.01 Billion | €5.56 Billion | €1.45 Billion | ▲ +2.6% |
| 2013 | 1.23x | €6.07 Billion | €4.94 Billion | €1.13 Billion | — |